Parkinson DiseasePARK-EHPADNCT06908460
Training of Nursing Home Professionals and Quality of Life of Residents With Parkinson's Disease
An observational study of Parkinson Disease, run by University Hospital, Grenoble at 1 site in France.
Trial summary
The complexity of medication treatments and the diversity of symptoms in Parkinson's disease (PD) require healthcare professionals to have specific knowledge of the disease in order to manage symptoms optimally and on an individualized basis. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Parkinson Disease
- How many people
- 90 participants
- Where
- 1 siteFrance
- Study dates
- 27 May 2025to 26 Aug 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: nursing home residents with Parkinson's disease
Who may be able to join
- Age ≥ 18 years
- Have a confirmed diagnosis of Parkinson's disease
- Reside in a nursing home (EHPAD) in the departments of 38, 73, 74, 26, and 07 in the AURA region
- Be able to cooperate and answer the questionnaires
Who cannot join
- Resident's opposition
- Subject to the provisions of articles L1121-5 to L1121-8 of the Public Health Code
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
CHU Grenoble Alpes
Grenoble, 38043
Céline PISCICELLI
Andréa KISTNER
About this study
Official title: The Link Between the Training of Nursing Home Professionals and the Quality of Life of Residents With Parkinson's Disease
The complexity of medication treatments and the diversity of symptoms in Parkinson's disease (PD) require healthcare professionals to have specific knowledge of the disease in order to manage symptoms optimally and on an individualized basis. This becomes even more important as the disease progresses due to the evolution of symptoms into fluctuating motor and non-motor manifestations. People with PD residing in nursing homes (EHPADs) often have multiple comorbidities, making care even more complex. A lack of specific knowledge among healthcare professionals in EHPADs can expose residents to an increased risk of complications and dependence, affecting their quality of life. Additionally, the complex symptoms of these residents can create concerns for care teams, which can act as a barrier to admitting this population of elderly people into these institutions. Thus, training professionals who care for and support elderly individuals with PD is a priority to optimize the healthcare journey for people with Parkinson's.
Interventions aimed at improving care quality are often implemented without evaluating their impact or using methodologies that do not provide scientific evidence justifying their generalization. Evaluating these interventions is essential to develop effective interventions within the healthcare system, contributing both to the improvement of care quality and to health policy. These interventions should undergo an evaluation of their positive and negative effects before being generalized.
Read more
The PARK-EHPAD study aims to assess the link between the training of healthcare professionals and the quality of life of elderly individuals with PD living in EHPADs. Since 2015, the Parkinson's Expert Center (CEP) at CHU Grenoble-Alpes, in partnership with the Regional Health Agency (ARS), has provided specific training on the multidisciplinary management of PD for healthcare professionals in EHPADs in five departments of the Auvergne Rhône-Alpes (AURA) region-Isère, Savoie, Haute-Savoie, Drôme, and Ardèche. The hypothesis is that this theoretical training program improves staff knowledge on PD-related topics, which should lead to optimized practices and a clinically significant improvement in the quality of life (primary outcome) for people with PD residing in EHPADs.
The impact of training on professionals' knowledge will be assessed in a prior study (PARK-EHPAD PRO), an RNIPH-type study that began in October 2024. PARK-EHPAD PRO will evaluate the impact of training on knowledge, competence, and comfort in working with people with Parkinson's among healthcare professionals in EHPADs receiving the training. This study will strengthen the results of the observational PARK-EHPAD study, which focuses on the relationship between healthcare professionals' training and the quality of life of PD residents.
Among various secondary hypotheses, it is also predicted that this theoretical training program will improve not only knowledge but also the sense of competence (secondary outcome) of healthcare professionals, which should lead to an improvement in the quality of life at work (QVT) for these residents (secondary outcomes).
The results of the PARK-EHPAD study could have significant clinical implications for both the care pathway of people with PD and public health policy. For people with PD, better training for healthcare professionals in EHPADs, leading to optimized care practices, will improve comfort and the management of disability at advanced stages of the disease. This benefit could extend to residents, caregivers, and their wider circle.
Demonstrating a link between professional training and residents' quality of life in EHPADs would provide a strong argument for advocating the nationwide expansion of specific training programs to other CEPs. This would help optimize the healthcare journey for elderly individuals with PD (disability management) and improve the quality of life for healthcare professionals in EHPADs. Indeed, improving professionals' sense of competence, better disability management for residents, and improved satisfaction for residents and their families should lead to better quality of life at work for EHPAD staff. This perspective is essential in light of societal public health challenges related to the recruitment and retention of healthcare professionals in such institutions.
- Conditions
- Parkinson Disease
- Keywords
- Parkinson's disease, nursing home, training
- Medical subject headings
- Parkinson Disease
What is being measured
The primary outcome is the main question the study is designed to answer.
Quality of Life-Alzheimer's Disease Scale (QOL-AD)
The QOL-AD is a validated questionnaire assessing quality of life in patients with Alzheimer's disease. The scale ranges from 13 to 52, with higher scores indicating better quality of life.of life of residents with Parkinson's disease.
Measured: single visit, 1 hour
Secondary outcomes (1)
Maslach Burnout Inventory (MBI) of healthcare professionals
The MBI is a validated questionnaire assessing burnout in healthcare professionals. It consists of three subscales: Emotional Exhaustion (score range 0-54), Depersonalization (score range 0-30), and Personal Accomplishment (score range 0-48). Higher scores on Emotional Exhaustion and Depersonalization indicate higher burnout levels (worse outcome), whereas higher scores on Personal Accomplishment indicate lower burnout (better outcome).
Measured: single visit, 1 hour
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Apr 2025
- Study start27 May 2025
- Primary completion26 Aug 2027 (estimated)
- Study completion26 Aug 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Parkinson DiseaseStudies of the same condition, open and under way.
- More trials run by University Hospital, GrenobleThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Retrospective
- Enrolment
- 90 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Grenoble
- Sponsor type
- University, hospital or other
- Collaborators
- France Parkinson Association
- Responsible party
- Principal investigator, Céline PISCICELLI, PhD, University Hospital, Grenoble
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06908460
- Sponsor's protocol ID
- PARK-EHPAD
- Other IDs
- 2024-A02733-44
- Acronym
- PARK-EHPAD
- Status last verified
- Aug 2025
- First submitted
- 13 Mar 2025
- Last updated
- 7 Aug 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 7 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Link Between the Training of Nursing Home Professionals and the Quality of Life of Residents With Parkinson's Disease
- ClinicalTrials.gov ID
- NCT06908460
- Acronym / sponsor ID
- PARK-EHPAD / PARK-EHPAD
- Conditions
- Parkinson Disease
- Keywords
- Parkinson's disease, nursing home, training
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 90 participants (estimated)
- Lead sponsor
- University Hospital, GrenobleUniversity, hospital or other
- Collaborators
- France Parkinson Association
- Study start
- 27 May 2025 (actual)
- Primary completion
- 26 Aug 2027 (estimated)
- Study completion
- 26 Aug 2027 (estimated)
- First posted
- 3 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The complexity of medication treatments and the diversity of symptoms in Parkinson's disease (PD) require healthcare professionals to have specific knowledge of the disease in order to manage symptoms optimally and on an individualized basis. This becomes even more important as the disease progresses due to the evolution of symptoms into fluctuating motor and non-motor manifestations. People with PD residing in nursing homes (EHPADs) often have multiple comorbidities, making care even more complex. A lack of specific knowledge among healthcare professionals in EHPADs can expose residents to an increased risk of complications and dependence, affecting their quality of life. Additionally, the complex symptoms of these residents can create concerns for care teams, which can act as a barrier to admitting this population of elderly people into these institutions. Thus, training professionals who care for and support elderly individuals with PD is a priority to optimize the healthcare journey for people with Parkinson's.
Interventions aimed at improving care quality are often implemented without evaluating their impact or using methodologies that do not provide scientific evidence justifying their generalization. Evaluating these interventions is essential to develop effective interventions within the healthcare system, contributing both to the improvement of care quality and to health policy. These interventions should undergo an evaluation of their positive and negative effects before being generalized.
The PARK-EHPAD study aims to assess the link between the training of healthcare professionals and the quality of life of elderly individuals with PD living in EHPADs. Since 2015, the Parkinson's Expert Center (CEP) at CHU Grenoble-Alpes, in partnership with the Regional Health Agency (ARS), has provided specific training on the multidisciplinary management of PD for healthcare professionals in EHPADs in five departments of the Auvergne Rhône-Alpes (AURA) region-Isère, Savoie, Haute-Savoie, Drôme, and Ardèche. The hypothesis is that this theoretical training program improves staff knowledge on PD-related topics, which should lead to optimized practices and a clinically significant improvement in the quality of life (primary outcome) for people with PD residing in EHPADs.
The impact of training on professionals' knowledge will be assessed in a prior study (PARK-EHPAD PRO), an RNIPH-type study that began in October 2024. PARK-EHPAD PRO will evaluate the impact of training on knowledge, competence, and comfort in working with people with Parkinson's among healthcare professionals in EHPADs receiving the training. This study will strengthen the results of the observational PARK-EHPAD study, which focuses on the relationship between healthcare professionals' training and the quality of life of PD residents.
Among various secondary hypotheses, it is also predicted that this theoretical training program will improve not only knowledge but also the sense of competence (secondary outcome) of healthcare professionals, which should lead to an improvement in the quality of life at work (QVT) for these residents (secondary outcomes).
The results of the PARK-EHPAD study could have significant clinical implications for both the care pathway of people with PD and public health policy. For people with PD, better training for healthcare professionals in EHPADs, leading to optimized care practices, will improve comfort and the management of disability at advanced stages of the disease. This benefit could extend to residents, caregivers, and their wider circle.
Demonstrating a link between professional training and residents' quality of life in EHPADs would provide a strong argument for advocating the nationwide expansion of specific training programs to other CEPs. This would help optimize the healthcare journey for elderly individuals with PD (disability management) and improve the quality of life for healthcare professionals in EHPADs. Indeed, improving professionals' sense of competence, better disability management for residents, and improved satisfaction for residents and their families should lead to better quality of life at work for EHPAD staff. This perspective is essential in light of societal public health challenges related to the recruitment and retention of healthcare professionals in such institutions.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- nursing home residents with Parkinson's disease
Key inclusion criteria (4 listed)
- Age ≥ 18 years
- Have a confirmed diagnosis of Parkinson's disease
- Reside in a nursing home (EHPAD) in the departments of 38, 73, 74, 26, and 07 in the AURA region
- Be able to cooperate and answer the questionnaires
Key exclusion criteria (2 listed)
- Resident's opposition
- Subject to the provisions of articles L1121-5 to L1121-8 of the Public Health Code
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Quality of Life-Alzheimer's Disease Scale (QOL-AD)
Time frame: single visit, 1 hour
The QOL-AD is a validated questionnaire assessing quality of life in patients with Alzheimer's disease. The scale ranges from 13 to 52, with higher scores indicating better quality of life.of life of residents with Parkinson's disease.
1 secondary outcome
Maslach Burnout Inventory (MBI) of healthcare professionals
Time frame: single visit, 1 hour
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Aug 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Parkinson Disease
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Enrolling by invitationObservational study
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
PARKINSON DISEASE (Disorder), Atypical Parkinsonism
RecruitingPhase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
Active, not recruitingPhase 1/2
Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease
Parkinson Disease (PD)
Active, not recruitingObservational study
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
Parkinson Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Parkinson Disease, run by University Hospital, Grenoble at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 7 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Céline PISCICELLI, PhD ((33) 4 76767575, cpiscicelli@chu-grenoble.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Quality of Life-Alzheimer's Disease Scale (QOL-AD) (time frame: single visit, 1 hour). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2025.